Articles

Drug development is a long and complex process that starts with discovery and, if successful, ends with government approval for marketing. Each step in the drug development process, outlined below, has specific goals with the aim of down-selecting appropriate...

With the growing number of clinical trials and new therapies entering the market, speed and flexibility are vital for market success. Achieving Good Manufacturing Practice (GMP) certification is critical to moving therapies forward; however, the complexities of navigating the...

Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases such as Amyotrophic Lateral Sclerosis (ALS) and spinal muscular atrophy, have a profound impact on patients and their families. Developing effective treatments for these conditions is faster when we have...

Scaling up production in the pharmaceutical industry is crucial for transitioning novel therapies from laboratory-scale development to large-scale manufacturing. This phase is essential for bringing life-saving medications to market, but it presents numerous technical, operational, and regulatory challenges. Addressing...

The landscape of drug discovery is evolving rapidly, driven by the need for innovative solutions to tackle complex diseases. Traditional R&D models, characterized by internal research silos, have increasingly shown limitations in addressing the complexities of modern biomedical challenges. The...

Motivated employees are critical for businesses. Motivation drives effective performance, and without sufficiently motivated employees (no matter how skilled), the chances of reaching organizational goals are reduced. For the pharmaceutical industry, as a high-stakes environment dealing with human health...

Establishing and running clinical trials can be fraught with hurdles, from patient recruitment and retention to ensuring regulatory compliance and data integrity. The research sites themselves also play a key role, as they impact a trial’s ability to include...